Nordtreat produces the world's first bio-based flame retardant technology, NORFLAMAE, for wood-based materials.
Nordtreat has raised $10.7M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2024.
Nordtreat's investors include UB FIGG, Altana, Taaleri Bioindustry, Taaleri.
Nordtreat is headquartered in Vantaa, Finland.
Nordtreat produces the world's first bio-based flame retardant technology, NORFLAMAE, for wood-based materials.
Nordtreat is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nordtreat — Funding & Investors." VCBacked, June 20, 2024, https://www.vcbacked.co/company/nordtreat. Accessed August 16, 2026.
VCBacked. (2024). Nordtreat — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/nordtreat
{{cite web |title=Nordtreat — Funding & Investors |url=https://www.vcbacked.co/company/nordtreat |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated